Author:
Abramson Jeremy S.,Stuver Robert,Herrera Alex,Patterson Emily,Wen Yi-Ping,Moskowitz Alison
Reference49 articles.
1. Brentuximab vedotin plus doxorubicin and dacarbazine in nonbulky limited-stage classical Hodgkin lymphoma;Abramson;Blood Adv,2023
2. ADCETRIS [prescribing information]. Bothell, WA: Seagen Inc, 2023.
3. Hodgkin lymphoma: 2018 update on diagnosis, risk-stratification, and management;Ansell;American Journal of Hematology,2018
4. Microtubule and tubulin binding and regulation of microtubule dynamics by the antibody drug conjugate (ADC) payload, monomethyl auristatin E (MMAE): Mechanistic insights into MMAE ADC peripheral neuropathy;Best;Toxicol Appl Pharmacol,2021
5. Treatment related morbidity in patients with classical Hodgkin lymphoma: Results of the ongoing, randomized phase III HD21 trial by the German Hodgkin Study Group;Borchmann;Blood,2022